Scientists at the Victor Chang Cardiac Institute in Australia have identified a Molecule that could be used to develop peptide-based drugs for Targeting Obesity, osteoporosis, and inflammatory diseases. The molecule regulates sensors called PIEZO ion channels, which play a role in various bodily processes, including sensing touch and pain. By modifying the molecule, researchers believe they can develop therapeutics to either increase or decrease the activity of these channels. The first targets for these therapeutics would be obesity and bone diseases. The molecule could also potentially be used to target inflammatory diseases and cardiovascular disease in the future.

The post Newly-Identified Molecule Could Be the Key to Targeting Obesity and Osteoporosis appeared first on Balanced News Summary.